TOMDF (Todos Medical) DeferredTaxAndRevenue: $0.00 Mil (As of Sep. 2022)


What is Todos Medical DeferredTaxAndRevenue?

Todos Medical TOMDF -90.00% DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2022.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Todos Medical's current deferred tax and revenue for the quarter that ended in Sep. 2022 was $0.00 Mil.

Todos Medical DeferredTaxAndRevenue Related Terms

Todos Medical DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Todos Medical's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical DeferredTaxAndRevenue Chart

Todos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.84 0.00

Todos Medical Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Todos Medical (TOMDF) has a DeferredTaxAndRevenue of $0.00 Mil as of Sep. 2022. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Todos Medical.
Is Todos Medical's DeferredTaxAndRevenue too high?
Todos Medical's current DeferredTaxAndRevenue is $0.00 Mil.
How does Todos Medical's DeferredTaxAndRevenue compare to NDRA and IDXG?
Todos Medical's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Diagnostics & Research company?
A good DeferredTaxAndRevenue depends on the Medical Diagnostics & Research industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Todos Medical. Todos Medical's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Todos Medical (TOMDF), the current DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Todos Medical Business Description

Address 121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.